Trials / Completed
CompletedNCT06369428
Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma Patients
Non-interventional Register-based Study to Analyze Patient Characteristics, Treatment Patterns and Healthcare Resource Utilization in Adult Patients With Metastatic Melanoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,795 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This was a retrospective, non-interventional, registry study based on secondary electronic medical record (EMR) data collected in Helsinki and Uusimaa hospital district (HUS data lake), hospital district of Southwest Finland (VSSHP data lake) and Pirkanmaa hospital district (PSHP data lake) as a part of their routine clinical practice. Social Insurance Institution of Finland (SII; reimbursed drug purchases) was utilized in this study to complement the medication data. The metastatic melanoma patients were stratified by first-line treatment and by hospital district.
Conditions
Timeline
- Start date
- 2021-06-23
- Primary completion
- 2023-04-13
- Completion
- 2023-04-13
- First posted
- 2024-04-17
- Last updated
- 2024-04-17
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06369428. Inclusion in this directory is not an endorsement.